Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 4Glioblastoma 3Brain Neoplasms 3Astrocytoma 2Oligodendroglioma 1Neoplasms 1Central Nervous System Diseases 1

Interventions

Temozolomide 38Radiotherapy 17Filgrastim 14Surgical Procedures, Operative 11Irinotecan 11Carmustine 10Carboplatin 10Radiation 9O(6)-benzylguanine 9Magnetic Resonance Spectroscopy 9Specimen Handling 7Granulocyte Colony-Stimulating Factor 7Flucytosine 7sargramostim 6Radiotherapy, Intensity-Modulated 5Peripheral Blood Stem Cell Transplantation 5Etoposide 5Erlotinib Hydrochloride 5Bevacizumab 5vocimagene amiretrorepvec 4Vorinostat 4Thiotepa 4Melphalan 4Lenalidomide 4IL13-PE38 4Genetic Therapy 4Cyclophosphamide 4Chemotherapy, Adjuvant 4Busulfan 4lonafarnib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Astrocytoma × Craniotomy × Clear all
NCT05789394 2026-04-02

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Mayo Clinic

Phase 1 Recruiting
20 enrolled
CNS

Astrocytoma, Glioblastoma

NCT01644955 2018-07-02

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡